Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer

Published:2021-06-21 Issue:1 Volume:88 Page:166-177
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Vera‐Yunca Diego¹²^ORCID,Parra‐Guillen Zinnia P.¹²^ORCID,Girard Pascal³,Trocóniz Iñaki F.¹²^ORCID,Terranova Nadia³^ORCID

Affiliation:

1. Pharmacometrics & Systems Pharmacology, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition University of Navarra Pamplona Spain

2. IdiSNA Navarra Institute for Health Research Pamplona Spain

3. Merck Serono S.A., Switzerland, an affiliate of Merck KGaA Merck Institute for Pharmacometrics Darmstadt Germany

Funder

Merck KGaA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14937

Reference42 articles.

1. Colorectal cancer